David Badawi - 19 Feb 2026 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Reporting relationship: Chief Technology Officer, Director
Issuer ticker: SGHT
Reported as of: 19 Feb 2026
Net transaction value: +$4,892
SEC form: 4
Accepted by SEC: 23 Feb 2026, 16:28:55 UTC
Prior SEC filing: 05 Feb 2026
Next SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/Jeremy Hayden, Attorney-in-Fact for David Badawi

Key filing fact

David Badawi filed Form 4 for Sight Sciences, Inc. (SGHT) on 23 Feb 2026.

Key facts

This page summarizes David Badawi's Form 4 filing for Sight Sciences, Inc. (SGHT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Feb 2026, 16:28.

Change

Previous filing in this sequence was filed on 05 Feb 2026.
Current net transaction value: +$4,892.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001870825 Primary reporting owner

Badawi David

Relationship: Chief Technology Officer, Director
Address: C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK
Signature: /s/Jeremy Hayden, Attorney-in-Fact for David Badawi
Signature date: 23 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGHT transaction

Common Stock

Options Exercise

Transaction value: $4,892
Shares: +21,270
Change %: +1.1%
Price: $0.2300
Shares after: 1,998,458
Date: 19 Feb 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGHT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -21,270
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 19 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,270
Exercise price: $0.2300
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects the exercise of stock options ("Options") awarded to the Reporting Person under the Issuer's equity incentive plan.

Footnote F2

Includes (i) 1,795,520 shares of common stock, and (ii) 202,938 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units that have not yet vested.

Footnote F3

The grant of Options made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options became fully vested and exercisable on January 1, 2020.